SCHEMBL1717876

SCHEMBL1717876

CCCCNC(=O)c1nn2c(C(F)(F)F)cc(-c3cccs3)nc2c1Br

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.70
KMT2A Q03164 5/20 0.70
MAPT P10636 4/20 0.70
MEN1 O00255 3/20 0.70
ESR1 P03372 1/20 0.70
POLB P06746 1/20 0.70
BLM P54132 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
RXFP1 Q9HBX9 2/20 0.68
SMN1; SMN2 Q16637 3/20 0.56
LMNA P02545 2/20 0.56
HTT P42858 2/20 0.56
HPGD P15428 6/20 0.51
TAAR1 Q96RJ0 1/20 0.51
KDM4E B2RXH2 8/20 0.51
GAA P10253 3/20 0.51
GLA P06280 1/20 0.49
CASP1 P29466 2/20 0.47
CASP7 P55210 2/20 0.47
HSD17B10 Q99714 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1718708 0.95 ALDH1A1 (0.72) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1719629 0.91 ALDH1A1 (0.65) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1718368 0.87 ALDH1A1 (0.69) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1719356 0.87 ALDH1A1 (0.71) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1718646 0.87 RXFP1 (0.74) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1718178 0.86 ALDH1A1 (0.80) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1719027 0.85 RXFP1 (0.80) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1718144 0.85 MAPT (0.64) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1717837 0.85 KMT2A (0.65) ALDH1A1KMT2AMAPTMEN1ESR1
SCHEMBL1719301 0.85 ALDH1A1 (0.76) ALDH1A1KMT2AMAPTMEN1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed